{
    "clinical_study": {
        "@rank": "105915", 
        "acronym": "Prepopik PREA", 
        "arm_group": [
            {
                "arm_group_label": "Prepopik\u2122 \u00bd sachet (9-12 years)", 
                "arm_group_type": "Experimental", 
                "description": "Prepopik\u2122 \u00bd sachet (9-12 years)"
            }, 
            {
                "arm_group_label": "Prepopik\u2122 1 sachet (9-12 years)", 
                "arm_group_type": "Experimental", 
                "description": "Prepopik\u2122 1 sachet (9-12 years)"
            }, 
            {
                "arm_group_label": "Oral polyethylene glycol (PEG) based preparation (9-12 years)", 
                "arm_group_type": "Active Comparator", 
                "description": "Local standard of care"
            }, 
            {
                "arm_group_label": "Prepopik\u2122 1 sachet (13-16 years)", 
                "arm_group_type": "Experimental", 
                "description": "Prepopik\u2122 1 sachet (13-16 years)"
            }, 
            {
                "arm_group_label": "Oral polyethylene glycol (PEG) based preparation (13-16 years)", 
                "arm_group_type": "Active Comparator", 
                "description": "Local standard of care"
            }
        ], 
        "brief_summary": {
            "textblock": "To study the efficacy and safety of Prepopik\u2122 in children aged 9 to 16 years for overall\n      colon cleansing in preparation of colonoscopy"
        }, 
        "brief_title": "Efficacy and Safety of Prepopik\u2122 in Children for Overall Colon Cleansing in Preparation for Colonoscopy", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Need for Bowel Preparation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, aged 9 years to 16 years, inclusive, being scheduled to undergo\n             elective colonoscopy\n\n          -  Subjects must have had 3 or more spontaneous bowel movements per week for 1 month\n             prior to the colonoscopy\n\n          -  Female subjects of childbearing potential must undergo a pregnancy test at screening\n             and again at randomization\n\n        Exclusion Criteria:\n\n          -  Acute surgical abdominal conditions (e.g., acute obstruction or perforation)\n\n          -  Hospitalized  for inflammatory bowel disease\n\n          -  Any prior colorectal surgery, excluding appendectomy, hemorrhoid surgery, or prior\n             endoscopic surgical procedures\n\n          -  Colon disease (history of colonic cancer, toxic megacolon, toxic colitis, idiopathic\n             pseudo obstruction, hypomotility syndrome, colon resection)\n\n          -  Ascites\n\n          -  Gastrointestinal disorder (active ulcer, outlet obstruction, retention,\n             gastroparesis, ileus)\n\n          -  Upper gastrointestinal surgery (gastric resection, gastric banding, gastric bypass)\n\n          -  Significant cardiovascular disease as determined by the investigator\n\n          -  If subject has a history of renal insufficiency, serum creatinine and potassium must\n             be within normal limits\n\n          -  Any clinically significant laboratory value at screening, including pre- existing\n             electrolyte abnormality, based on clinical history\n\n          -  Hypersensitivity to active ingredients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "16 Years", 
            "minimum_age": "9 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01928862", 
            "org_study_id": "000103"
        }, 
        "intervention": [
            {
                "arm_group_label": "Prepopik\u2122 \u00bd sachet (9-12 years)", 
                "intervention_name": "Prepopik\u2122 \u00bd sachet (9-12 years)", 
                "intervention_type": "Drug", 
                "other_name": "Prepopik\u2122"
            }, 
            {
                "arm_group_label": "Prepopik\u2122 1 sachet (9-12 years)", 
                "intervention_name": "Prepopik\u2122 1 sachet (9-12 years)", 
                "intervention_type": "Drug", 
                "other_name": "Prepopik\u2122"
            }, 
            {
                "arm_group_label": "Oral polyethylene glycol (PEG) based preparation (9-12 years)", 
                "intervention_name": "Oral polyethylene glycol (PEG) based preparation (9-12 years)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Prepopik\u2122 1 sachet (13-16 years)", 
                "intervention_name": "Prepopik\u2122 1 sachet (13-16 years)", 
                "intervention_type": "Drug", 
                "other_name": "Prepopik\u2122"
            }, 
            {
                "arm_group_label": "Oral polyethylene glycol (PEG) based preparation (13-16 years)", 
                "intervention_name": "Oral polyethylene glycol (PEG) based preparation (13-16 years)", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 9, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "University of Alabama"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana"
                    }, 
                    "name": "IU Medical Center / Riley Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland"
                    }, 
                    "name": "John Hopkins"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "University of Minnesota"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stony Brook", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Stony Brook Children's"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "Nationwide Children's Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "Children's Hospital of Pittsburgh"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }, 
                    "name": "Vanderbilt University Medical Center"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "5", 
        "official_title": "A Randomized, Assessor-Blind, Multicenter, Dose-Ranging Study Comparing the Safety and Efficacy of Prepopik\u2122 Versus Polyethylene Glycol Preparation (Local Standard of Care) in Children Aged 9 Years to 16 Years", 
        "overall_contact": {
            "email": "DK0-Disclosure@ferring.com", 
            "last_name": "Clinical Development Support"
        }, 
        "overall_official": {
            "affiliation": "Ferring Pharmaceuticals", 
            "last_name": "Clinical Development Support", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of subjects defined by \"excellent\" or \"good\" in the Aronchick Scale", 
            "safety_issue": "No", 
            "time_frame": "1 day of colonoscopy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01928862"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 33 days after colonoscopy"
            }, 
            {
                "measure": "Incidence of abnormal findings in laboratory tests", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 7 days post colonoscopy"
            }, 
            {
                "measure": "Incidence of abnormal findings in physical exams", 
                "safety_issue": "Yes", 
                "time_frame": "From up to 21 days prior to colonoscopy and at the day of colonoscopy"
            }, 
            {
                "measure": "Number of subjects who took the assigned dose for colon cleansing", 
                "safety_issue": "No", 
                "time_frame": "approx. 1 day  (From the day before colonoscopy to the day of colonoscopy)"
            }, 
            {
                "measure": "Frequency of each category of the \"Subject's Tolerability and Satisfaction Questionaire\"", 
                "safety_issue": "No", 
                "time_frame": "1 day of colonoscopy"
            }, 
            {
                "description": "For PK sampling 5 subjects per treatment group will be assessed", 
                "measure": "Pharmacokinetic (PK) assessment: Cmax (maximum concentration of drug in the blood)", 
                "safety_issue": "No", 
                "time_frame": "Up to 7 days after colonoscopy"
            }, 
            {
                "description": "For PK sampling 5 subjects per treatment group will be assessed", 
                "measure": "PK assessment: Tmax (time when maximum concentration of drug in the blood is achieved)", 
                "safety_issue": "No", 
                "time_frame": "Up to 7 days after colonoscopy"
            }, 
            {
                "description": "For PK sampling approximately 5 subjects per treatment group will be assessed", 
                "measure": "PK assessment: AUC (area under the curve correlates with the total amount of drug exposure in the blood)", 
                "safety_issue": "No", 
                "time_frame": "Up to 7 days after colonoscopy"
            }
        ], 
        "source": "Ferring Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ferring Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}